The Multiple Sclerosis Severity Score: associations with MC1R single nucleotide polymorphisms and host response to ultraviolet radiation

Abstract

Background: Multiple sclerosis outcome may be influenced by ultraviolet radiation and vitamin D synthesis, suggesting skin type and genes determining this phenotype are candidates for disability. However, though associations between melanocortin 1 receptor (MC1R) single nucleotide polymorphisms and disability are reported, some data are incompatible with their expected influence on skin type.

Objective: Determine which MC1R single nucleotide polymorphisms affect disability and establish if ultraviolet radiation modifies such associations.

Methods: We studied using linear regression in 525 cases, associations of the Multiple Sclerosis Severity Score (MSSS) with skin type, gender, ultraviolet radiation exposure and six MC1R single nucleotide polymorphisms (rs1805005, rs1805006, rs2228479, rs1805007, rs1805008, rs1805009).

Results: CG²⁹⁴ with GG²⁹⁴ genotypes (rs1805009) (coefficient = —1.44, 95% CI —2.30, —0.59, mean MSSS ± SD = 4.33 ± 2.87) and AC⁸⁴ (rs1805006) (coefficient = 1.62, 95% CI 0.17, 3.06, mean MSSS = 7.62 ± 2.43) were associated with MSSS. Associations with Asp294His were found in those with skin types 1/2 and 3/4, and cases stratified by ultraviolet radiation exposure. However, they were seen only in cases with a history of childhood sunburn and not in those without sunburn. We found no significant associations between exposure parameters and MSSS.

Conclusions: Multiple Sclerosis outcome is influenced by interactions between host response to ultraviolet radiation and MC1R single nucleotide polymorphisms. The influence of the single nucleotide polymorphisms appears distinct from their association with skin type.

Keywords

disability evaluation MC1R MSSS multiple sclerosis ultraviolet radiation

Get full access to this article

View all access options for this article.

References

Confavreux C. , Vukusic S. and Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003; 126: 770-782.

Kurtzke JF Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.

Confavreux C. and Vukusic S. Age at disability milestones in multiple sclerosis . Brain 2006; 129: 595-605.

Hensiek AE , Sawcer SJ and Compston DA Searching for needles in haystacks - the genetics of multiple sclerosis and other common neurological diseases. Brain Res Bull 2003; 61: 229-234.

Dean G. and Elian M. Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis. J Neurol Neurosurg Psychiatry 1997; 63: 565-568.

Weinshenker BG , Bass B. , Rice GP , et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989; 112: 133-146.

Hayes CE , Cantorna MT and DeLuca HF Vitamin D and multiple sclerosis. Proc Soc Exp Biol Med 1997; 216: 21-27.

Soilu-Hänninen M. , Laaksonen M. , Laitinen I. , et al. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J Neurol Neurosurg Psychiatry 2008; 79: 152-157.

van der Mei lA , Ponsonby AL , Dwyer T. , et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. Br Med J 2003; 327-316.

10.

Smolders J. , Menheere P. , Kessels A. , et al. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler 2008; 14: 1220-1224.

11.

Westberg M. , Feychting M. , Jonsson F. , et al. Occupational exposure to UV light and mortality from multiple sclerosis. Am J Ind Med 2009; 52: 353-357.

12.

Mahon BD , Gordon SA , Cruz J. , et al. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 2003; 134: 128-132.

13.

Embry AF , Snowdon LR and Vieth R. Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 2000; 48: 271-272.

14.

Correale J. , Ysrraelit MC and Gaitán MI. Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain 2009; 132: 1146-1160.

15.

Woolmore JA , Stone M. , Pye EM , et al. Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation. Mult Scler 2007; 13: 369-375.

16.

Kragt J. , van Amerongen B. , Killestein J. , et al. Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler 2009; 15: 9-15.

17.

Ramagopalan SV , Maugeri NJ , Handunnetthi L. , et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet 2009; 5: e1000369.

18.

Dwyer T. , van der Mei I. , Ponsonby A-L. , et al. Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis. Neurology 2008; 71: 583-589.

19.

Fitzpatrick TB The validity and practicality of sun-reactive skin types 1 through VI. Arch. Dermatol 1988 ; 124: 869-871.

20.

Rees JL The genetics of sun sensitivity in humans. Am J Hum Genet 2004; 75: 739-751.

21.

Deluca HF and Cantorna T. Vitamin D: its role and uses in immunology. FASEB J 2001; 15: 2579-2585.

22.

Partridge JM , Weatherby SJ , Woolmore JA , et al. Susceptibility and outcome in MS: associations with polymorphisms in pigmentation-related genes. Neurology 2004; 62: 2323-2325.

23.

Roxburgh RH , Seaman SR , Masterman T. , et al. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 2005; 64: 1144-1151.

24.

Rukin NJ , Zeegers MP , Ramachandran S. , et al. A comparison of sunlight exposure parameters in men with prostate cancer and basal cell carcinoma. Br J Cancer 2007; 96: 523-528.

25.

Islam T. , Gauderman WJ , Cozen W. , et al. Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins. Neurology 2007; 69: 381-388.

26.

Caron-Schreinemachers AJ , Kingswijk MM , Bos JD , et al. UVB 311 nm tolerance of vitiligo skin increases with skin photo type. Acta Derm Venereol 2005; 85: 24-26.

27.

Ziegler AG , Baumgartl HJ , Ede G. , et al. Low-pigment skin type and predisposition for development of type 1 diabetes. Diabetes Care 1990; 13: 529-531.

28.

Miyachi Y. , Horio T. and Imamura S. Sunburn cell formation is prevented by scavenging oxygen intermediates. Clin Exp Dermatol 1983; 8: 305-310.

29.

Rukin N. , Blagojevic M. , Luscombe CJ , et al. Associations between timing of exposure to ultraviolet radiation, T-stage and survival in prostate cancer. Cancer Detect Prev 2007; 31: 443-449.

30.

Cooper A. , Robinson SJ , Pickard C. , et al. Alpha-melanocyte-stimulating hormone suppresses antigen-induced lymphocyte proliferation in humans independently of melanocortin 1 receptor gene status. J Immunol 2005; 175: 4806-4813.